Akolkar Aparna S MD is categorized under Internal Medicine Practitioners in Costa Mesa, CA and active since 2012.
Akolkar Aparna S MD was established in 2012, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Aparna Akolkar at the company’s single location by writing to 1665 Scenic Avenue # 100, Costa Mesa, California CA 92626 or by phoning (714) 436-4700. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Akolkar Aparna S MD |
| Contact Person: | Aparna Akolkar |
| Address: | 1665 Scenic Avenue # 100, Costa Mesa, California 92626 |
| Phone Number: | (714) 436-4700 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Practitioners |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Akolkar Aparna S MD was started in 2012 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Aparna Akolkar for inquiries that concern Akolkar Aparna S MD by calling the company number (714) 436-4700, as your correspondence is most welcome. Additionally, the physical location of the single location of Akolkar Aparna S MD can be found at the coordinates 33.69927,-117.9266 as well as the street address 1665 Scenic Avenue # 100 in Costa Mesa, California 92626.
For its online presence, you may visit Akolkar Aparna S MD’s website at and engage with its social media outlets through on Twitter and on Facebook.